Health Condition 1: F422- Mixed obsessional thoughts and acts Health Condition 2: F429- Obsessive-compulsive disorder, unspecified Health Condition 3: F428- Other obsessive-compulsive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults over age 18 years; 2. Primary diagnosis of DSM-5 OCD; 3. Y-BOCS total severity score between 14 - 30; 4. On stable medications for at least 8 weeks prior to inclusion.
Exclusion criteria
Exclusion criteria: 1. Severe comorbid psychiatric conditions such as high suicide risk (as determined by SCID-CV screening questions on suicidality), severe major depression, psychosis, bipolar disorder, substance dependence (other than tobacco); 2. Clinically determined Intellectual or other developmental disability that may compromise the ability to consent and participate in CBT; 3. Having received CBT of at least 10 sessions for OCD in the past year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in total score of Yale-Brown Obsessive Compulsive Scale which assess Obsessive compulsive symptom severity.Timepoint: Outcome assessments will be done by independent assessors who will be blind to the allocation. The primary end-point of the study will be after the intervention (Three months of intervention in both groups). The primary outcome in both groups will be assessed every two weeks during the intervention and one month and six months of follow-up. This would enable us to evaluate the rapidity and the sustainability of response. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the Global Assessment of Functioning & World Health Organization Quality of Life-Brief scores will be the outcome variable.Timepoint: Baseline, post-intervention, one-month, & six-month follow-up will be used as time points for the assessment of functioning & quality of life using the Global Assessment of Functioning & World Health Organization Quality of Life-Brief.;Reduction of total score on Hamilton Anxiety Rating Scale will be secondary outcome variable.Timepoint: Baseline, post intervention, one month & six month follow ups will be considered the time point for assessing patients level of level of Anxiety using Hamilton Anxiety Rating Scale.;Reduction of total score on Montgomery-Åsberg Depression Rating Scale which assess severity of depression.Timepoint: Baseline, post intervention, one month & 6 month follow ups will be used the time point for assessing patients level of depression by using Montgomery-Åsberg Depression Rating Scale. | — |
Countries
India
Contacts
National Institute of Mental Health and Neurosciences